Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.

Annals of transplantation : quarterly of the Polish Transplantation Society

Volumn 7, Issue 3, 2002, Pages 28-31

  Wlodarczyk Z ^a   Walaszewski J ^a   Perner, F ^a   Vitko, S ^a   Ostrowski, M ^a   Bachleda, P ^a   Kokot, F ^a   Klinger, M ^a   Szenohradsky, P ^a   Studenik, P ^a   Navratil, P ^a   Asztalos, L ^a   Rutkowski, B ^a   Nagy, K Kalmar ^a   Hickey, D ^a  

^a District Hospital in Poznan   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REOPERATION; STATISTICS;

ADULT; AZATHIOPRINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; REOPERATION; STEROIDS; TACROLIMUS; TISSUE DONORS;

EID: 0036361019     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)